US Bancorp’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4K Buy
+572
New +$1.15K ﹤0.01% 3878
2025
Q3
Sell
-184
Closed -$208 4007
2025
Q2
$208 Sell
184
-6,784
-97% -$9.02K ﹤0.01% 4076
2025
Q1
$10.2K Buy
6,968
+6,229
+843% +$11.7K ﹤0.01% 3429
2024
Q4
$1.57K Sell
739
-1,043
-59% -$2.57K ﹤0.01% 3898
2024
Q3
$4.99K Buy
1,782
+212
+14% +$565 ﹤0.01% 3568
2024
Q2
$3.66K Sell
1,570
-1,813
-54% -$5.35K ﹤0.01% 3597
2024
Q1
$15.1K Hold
3,383
﹤0.01% 3194
2023
Q4
$10.9K Buy
3,383
+826
+32% +$2.34K ﹤0.01% 3299
2023
Q3
$8.11K Buy
2,557
+859
+51% +$3.76K ﹤0.01% 3250
2023
Q2
$8.44K Buy
1,698
+1,210
+248% +$6.54K ﹤0.01% 3323
2023
Q1
$2.41K Sell
488
-2,842
-85% -$18.2K ﹤0.01% 3711
2022
Q4
$20.9K Sell
3,330
-1,593
-32% -$14.7K ﹤0.01% 2973
2022
Q3
$54K Sell
4,923
-551
-10% -$7.49K ﹤0.01% 2483
2022
Q2
$63K Buy
5,474
+1,616
+42% +$14.3K ﹤0.01% 2463
2022
Q1
$35K Buy
3,858
+1,010
+35% +$10.5K ﹤0.01% 2790
2021
Q4
$42K Buy
2,848
+2,301
+421% +$40.6K ﹤0.01% 2737
2021
Q3
$14K Sell
547
-9,863
-95% -$234K ﹤0.01% 3285
2021
Q2
$271K Buy
10,410
+42
+0.4% +$1.2K ﹤0.01% 1846
2021
Q1
$366K Buy
10,368
+10,071
+3,391% +$340K ﹤0.01% 1654
2020
Q4
$7K Buy
297
+247
+494% +$8.05K ﹤0.01% 3292
2020
Q3
$2K Sell
50
-23
-32% -$867 ﹤0.01% 3468
2020
Q2
$3K Buy
73
+23
+46% +$832 ﹤0.01% 3415
2020
Q1
$1K Hold
50
﹤0.01% 3533
2019
Q4
$1K Hold
50
﹤0.01% 3541
2019
Q3
$1K Buy
+50
New +$1.42K ﹤0.01% 3470

Other funds holding ALLO